Bio-Techne Launches Cultrex™ Synthetic Hydrogel to Enhance Reproducibility in 3D Organoid Culture
Exhibitor: HONG JING CO., LTD.
Date: 2026-05-11
Booth No.: M1028
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
Bio-Techne announced the launch of Cultrex™ Synthetic Hydrogel, a fully defined synthetic extracellular matrix (ECM), expanding its established Cultrex™ ECM portfolio and providing researchers with a more reproducible and scalable solution for 3D stem cell and organoid culture workflows.
Cultrex™ Synthetic Hydrogel is designed to reduce lot-to-lot variability commonly associated with traditional biologically derived matrices. By offering a fully defined composition, it enables more consistent experimental conditions across studies and laboratories, improving reproducibility and data reliability in 3D culture systems.
The product supports a broad range of organoid applications, including drug screening, toxicology studies, and personalized medicine research, while reducing reliance on animal-derived matrices and supporting the adoption of New Approach Methodologies (NAMs).
From a regulatory perspective, Cultrex™ Synthetic Hydrogel aligns with FDA initiatives aimed at improving translational predictability by enabling more robust and standardized preclinical models. Its defined composition supports consistency, traceability, and scalability for workflows advancing toward regulatory-facing studies.
Will Geist, President of the Protein Sciences Segment at Bio-Techne, commented:
“This product reflects the evolving needs of researchers as stem cell and organoid models move more quickly from discovery into translational workflows. Cultrex™ Synthetic Hydrogel expands our ECM portfolio with a fully defined, scalable solution that enhances reproducibility and consistency without compromising performance.”
This launch further strengthens Bio-Techne’s comprehensive Cultrex™ portfolio, which includes Basement Membrane Extracts (BME), recombinant proteins, cytokines and growth factors, AI-modified proteins, small molecules, media, and supplements—offering researchers a complete toolbox for 3D culture applications.
As the authorized Bio-Techne distributor in Taiwan, HongJin Co., Ltd. continues to support local researchers with Cultrex™ ECM products and 3D stem cell and organoid culture solutions, providing technical support and application guidance to accelerate research in regenerative medicine, drug discovery, and translational science.
More Exhibitor's Press Release
- With over 30 years of experience in automation equipment RADEN AUTOMATIC LTD. / 2026-05-12
- Common Instruments for Nucleic Acid Concentration Detection MEDCLUB SCIENTIFIC CO., LTD. / 2026-05-12
- Feyond-MF200 Multi-Mode Microplate Reader Launched! MEDCLUB SCIENTIFIC CO., LTD. / 2026-05-12
- Multiplex qPCR vs. Singleplex qPCR: Key Differences, Benefits, and Experimental Considerations MEDCLUB SCIENTIFIC CO., LTD. / 2026-05-12
- QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, W QPS HOLDINGS, LLC / 2026-05-11
- QPS Selects Oracle Argus Safety Database QPS HOLDINGS, LLC / 2026-05-11
- QPS Celebrates 30th Anniversary QPS HOLDINGS, LLC / 2026-05-11
- Bio-Techne Expands COMET™ Spatial Biology Portfolio with New SPYRE™ Solutions HONG JING CO., LTD. / 2026-05-11
- Aiming for a Guinness World Record! The 3rd International Traditional & Natural Medicine Congress to MEDITHEK ENTERPRISES LTD. / 2026-05-11
- Pharmaceutical Company Donates 3,000 ““AHCHOO” Herbal Sprays to Support Vulnerable Communities Durin MEDITHEK ENTERPRISES LTD. / 2026-05-11
- Rotary International Donates “AHCHOO” Herbal Spray to Tri-Service General Hospital, Supporting Front MEDITHEK ENTERPRISES LTD. / 2026-05-11
- Consumer-Friendly Jelly Formats Redefine Health Supplements with Both Functionality and Enjoyment JOWIN BIOPHARMA, INC. / 2026-05-07
- Highest Cell Viability in Perfusion LEVITRONIX GMBH TAIWAN BRANCH / 2026-05-05
- The Fastest and Safest Depth Filtration LEVITRONIX GMBH TAIWAN BRANCH / 2026-05-05
- Next Generations Therapy Manufacturing LEVITRONIX GMBH TAIWAN BRANCH / 2026-05-05
- Youlin Pharmaceutical Debuts at BIO Asia-Taiwan 2026 — Accelerating New Drug Clinical Development wi SHANGHAI UNIONCLIN CO,. LTD.(UNIONCLIN) / 2026-04-29
- BioLegend Introduces Cell-Vive™ GMP Solutions to Streamline and Scale Cell Therapy Manufacturing BIOLEGEND TAIWAN INC. / 2026-04-28
- Revolutionizing Production Efficiency! Singhania Tableting Unveils One-Stop Smart Tableting Solution ATTRA GIAND INDUSTRIAL CO., LTD. / 2026-04-24
- KMU to Showcase 50+ Cutting-Edge Medical Innovations at BIO Asia–Taiwan 2026 KAOHSIUNG MEDICAL UNIVERSITY / 2026-04-22
- Thermo Fisher Genesys UV Visible Spectrophotometer CHIEFDOM-TEK CO., LTD. / 2026-04-22